Conference Reports for NATAP

IAS 2017: Conference on HIV Pathogenesis Treatment and Prevention Paris, France July 23-26 2017 Back

IAS: Stigma, New HIV Infections Up in Key Populations, PrEP Access Disparities, Poor Adherence in Medicaid, High Comorbidities in Canada, Immunosenescence in HIV+ Kids, Health Outcomes-Women who have Sex with Women/Transgender Women-US       IAS: Experience of Living With HIV: Diagnosis and Disclosure - Findings From the Positive Perspectives Study - self-stigma is high, 63% of older HIV+ have 3+ Comorbidities - (08/02/17) - this study reports - stigma prevails: high self-stigma, depression & poor mental health/anxiety, little support; 63% 3+ Comorbidities among age 50+ 3 times greater than 18-34 years old   IAS: Health behaviors and outcomes in a U.S. cohort of transgender women in HIV care - (08/08/17)   ......More Depression, Worse Quality of Life in Transgender Women vs Men With HIV   IAS: New HIV Down in US MSM in 2008-2014, But Up in Hispanics, Younger Men - (07/28/17)   IAS: HIV Risk Factors and Associated Health Outcomes Among Sexual Minority Women in the United States - Sexual Violence, Drug Injecting, Risky Sex With Men Tied to STI Risk in US Lesbians (08/07/17)   IAS: Half of HIV+ Medicaid Users Have Poor Adherence, Driving Up Costs (08/06/17)   IAS: DISPARITIES Changes in Truvada® for HIV Pre-exposure Prophylaxis Utilization in the USA: 2012-2016 - Disparities - (08/02/17)   IAS:HIV mediated immunosenescence in young adults infected at birth [and HIV+ adults too despite undetectable VL] - (07/31/17)   IAS: Canada - Prevalence of Comorbidities and Impact of HIV and Comorbidities on Health Care Resource Utilization - (08/03/17) IAS: New HIV & HCV Drugs at IAS / Dual ARTs / Fatty Liver in HIV+ - (08/09/17)   IAS: PrEP at IAS 2017 / IAS Coverage: New HIV & HCV Drugs, Fatty Liver in HIV - (08/11/17)   100 +Reports IAS 2017: Conference on HIV Pathogenesis Treatment and Prevention Paris, France July 23-26 2017